MSBi Valorisation
MSBi Valorisation is a company.
Active
Updated: ·
Financial History
Total Raised
N/A
Valuation
N/A
Leadership Team
Key people at MSBi Valorisation.
MSBi Valorisation is a company.
Key people at MSBi Valorisation.
MSBi Valorisation is a Canadian venture initiative affiliated with MSBi Capital (now evolved into iNovia Capital), focused on technology transfer and valorization of university research into commercial startups. Launched around 2004 with financing from MSBi Capital and Canada Economic Development for Quebec (DEC, contributing $4 million), it managed seed and early-stage investments, particularly in spinouts from universities like McGill, Sherbrooke, and Bishop’s.[2][3][4] Its mission centered on enhancing market value through innovative solutions for businesses, bridging academic IP to viable companies in sectors such as software, semiconductors, biotech, and materials science, while supporting the startup ecosystem via selective funding for high-potential spinouts.[1][2]
With a track record of 3 total investments, 1 exit, and an average of 0.17 rounds per year, MSBi Valorisation emphasized university-backed tech commercialization rather than broad venture scaling, distinguishing it from larger funds like iNovia.[2][6]
MSBi Valorisation emerged from MSBi Capital ("i" for Innovations), established in 2001-2002 with $26 million initial capitalization, backed by $11 million from McGill, Sherbrooke, and Bishop’s Universities (plus hospital institutes) and $15 million from a valorisation fund.[2][5] Key figures included Mark de Groot, a physicist and serial entrepreneur who cofounded University Medical Discoveries (later MDS Capital), hired as CEO to drive research-based investments; he aimed to replicate successes like ACELP by focusing on university spinouts.[2]
The idea stemmed from Quebec universities' need for a dedicated venture fund amid a tough 2002 VC market, leading to a pivot from planned 50 investments to selective backing of just over a dozen spinouts. MSBi Valorisation was announced in 2004 as a specialized arm, financed jointly by MSBi Capital and DEC, to handle technology transfer—evolving alongside iNovia's growth into a billion-AUM international firm with offices across Canada, the US, and UK.[2][3][4]
MSBi Valorisation rode the early-2000s wave of university tech commercialization in Canada, amid efforts to rival US hubs by monetizing public research—part of a trend spawning entities like Univalor, Sovar, and Gestion Valeo under iNovia.[2] Timing was critical post-dotcom bust, when selective, IP-driven investing countered market contraction, influencing Quebec's ecosystem by funding spinouts that interacted with external seed funds.[2]
It bolstered Canada's startup landscape by proving government-university hybrids could yield exits, paving the way for iNovia's global expansion and emphasizing biotech/materials amid rising demand for research-derived innovation.[2][6]
MSBi Valorisation's legacy as a nimble tech transfer specialist positions it as a foundational piece of Canada's VC evolution, now absorbed into iNovia's broader portfolio. Next steps likely involve sustained spinout support amid AI/biotech booms, with trends like increased government R&D funding (echoing its DEC roots) shaping growth. Its influence may grow through iNovia's scale, amplifying Quebec's role in global deep tech—tying back to its core strength in turning university IP into market value.
Key people at MSBi Valorisation.
